The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Riken Corp. engages in the manufacture and sale of engine and vehicular components. It operates through the Automotive and Machinery Parts, and Others segments. The Automotive and Machinery Parts segment deals with the company's core products such as piston rings, camshafts, seal rings for transmissions, high-grade cast iron products, and valve lifters. The Others segment includes plumbing equipment business, Electromagnetic Compatibility (EMC) business, and thermal engineering business, The company was founded by Masatoshi Okochi in November 1927 and is headquartered in Tokyo, Japan.

Nevada Cancer Institute (NVCI), founded in 2002, was the official cancer institute for the state of Nevada from 2003 to 2013, located in Summerlin, Nevada. The Institute became part of UC San Diego Health in February, 2012.

NantKwest is a clinical-stage immunotherapy company focused on harnessing the immune system to treat disease. It is a biotechnology company, engages in developing immunotherapeutic agents for various clinical conditions in the United States. The company’s product candidates include activated natural killer candidates for the treatment of virally-induced cancers, such as human papilloma virus-induced cervical, and head and neck cancers; ebola; and serious viral, fungal, and bacterial infections, as well as that is in Phase II clinical trials for the treatment of polyoma virus-induced merkel cell carcinoma.

The Eli and Edythe L. Broad Institute of MIT and Harvard (/ˈbroʊd/), often referred to as the Broad Institute, is a biomedical and genomic research center located in Cambridge, Massachusetts, United States. The institute is independently governed and supported as a 501(c)(3) nonprofit research organization under the name Broad Institute Inc., and is partners with Massachusetts Institute of Technology, Harvard University, and the five Harvard teaching hospitals.

Celgene Corporation is an American biotechnology company that discovers, develops and commercializes medicines for cancer and inflammatory disorders. It is incorporated in Delaware and headquartered in Summit, New Jersey. The company's major product is Revlimid (lenalidomide), in combination with dexamethasone for the treatment of multiple myeloma patients. Revlimid is also approved in the United States for the treatment of patients with transfusion-dependent anemia, due to Low- or Intermediate-1-risk Myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. Revlimid is sold through proprietary risk-management distribution programs, to ensure safe and appropriate use of these pharmaceuticals. Vidaza is approved for the treatment of patients with MDS.

BC Cancer Agency provides healthcare services. The firm serves for hereditary cancer, indigenous cancer care, interpreters, and psychiatry. Its services include assessment and follow-up library, nutrition services, pain and symptom management, patient and family counselling, PET functional imaging, primary care, screening programs, and speech-language pathology. The company was founded on November 5, 1938 and is headquartered in Vancouver, Canada.

National Cancer Center Korea is a South Korean company located in Goyang-si and ultimately controlled by the Government of South Korea. The firm provides clinical and medical research services.

Flash is developing an oral compound to prevent AML relapse using novel findings linking HCK to AML. This small molecule will inhibit HCK and FLT3-ITD for the treatment of cancer. They have identified five potential compounds for further testing. One is moving on to IND filing while the other four are going to begin animal toxicology testing.

University Health Network (UHN) is a healthcare and medical research organization in Toronto, Ontario, Canada. It is the largest such research organization in Canada and North America, ranking first in Canada for total research funding. It was named Canada's top research hospital by Research Infosource in 2015, 2016 and 2017. It was created in 1986 by the Government of Ontario through the merger of four major hospitals: Toronto General Hospital, Toronto Western Hospital, with the Princess Margaret Cancer Centre, and the Toronto Rehabilitation Institute merged in with The Toronto Hospital in 1999 and the name changed to the University Health Network. All four hospitals are affiliated with the Faculty of Medicine at the University of Toronto and serve as teaching hospitals for resident physicians, nurses, and other healthcare professions. UHN also operates The Michener Institute, an applied health sciences college that opened in 1958.

Hangzhou Yongshen Biotechnology Co., Ltd., established on 2019-01-25, Business scope includes technology development,Technical Services,technical consulting,Achievement transfer:Biotechnology,Pharmaceutical Intermediates,Chemical raw materials and products,Instrumentation.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Beijing Yuehao Technology Development Co., Ltd., established on 2017-09-08, Business scope includes technology development,technical consulting,technology transfer,Technical Services;Computer System Services;Business Management Consulting;market survey;design,make,acting,Place an ad;Conference Services;Undertake exhibition and display activities;translation service.(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

CSL Limited is a public company which is a parent company of the CSL Group. CSL business activities operate in the Human Health, JRH Biosciences, Animal Health and ZLB Plasma Services operations. CSL limited develops, manufactures and markets pharmaceutical products of biological origin. The company' s business is: - Health care; - Life-saving products derived from human plasma; - Pharmaceuticals and diagnostics essential to health; - Cell culture reagents for the pharmaceutical industry; - Veterinary vaccines and diagnostics to protect livestock and companion animals.

Bi Shen Kong Gu You Xian Gong Si, established on 2017-05-22, Business scope includes engineering and technology research and experimental development;Engineering and Technology Basic Science Research Services;Materials Science Research,technology development;Technical Research on Landscape Architecture Engineering,to develop;New material technical consultation,communication service;New material technology transfer service;Agricultural Technology Development Services;Agricultural technology transfer service;Biotechnology Development Services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;New material technology development service;Energy saving technology development service;Energy Management Services;Mechanical Technology Development Services;Environmental Technology Development Services;Environmental Technology Consulting,communication service;Water resource management technology transfer service;Ecological Restoration Technology Transfer Service;Biological control technology development services;Research and development and technology transfer of health science;Engineering Technology Consulting Services;trade agent;Commodity wholesale trade(Except for licensed and approved products);Commodity retail trade(Except for licensed and approved products);Trade Advisory Services;

Shenzhen Hansheng Huirong Regenerative Medicine Technology Co., Ltd., established on 2019-03-27, Business scope includes general business items:Biotechnology R&D,technology transfer,technical consulting,Technical Services;Biomaterials R&D;Improvements in bioprocessing technology;commissioned biological cell culture(Except for special approval);medical instruments,food research and development;Health products,cosmetic,disinfect,Research and development of hygienic insecticide products,Sales(In addition to chemical hazards);umbilical cord,placenta,Umbilical cord blood stem cell technology development and storage services;Cell Product Testing;Cell Drug Development;Cell Therapy Raw Adjuvant Products,Technology development of gene medicine;Research and development of cell beauty products,technical consulting.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments),The licensing program is:

Guangzhou Baiji Gene Technology Co., Ltd., established on 2015-07-24, Business scope includes technical services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Development of Human Gene Diagnosis and Therapy Technology;Nursing facility services(Does not include medical services);Medical equipment rental;Human stem cell technology development and application;R&D and application of cell technology;Sales of hygiene products and single-use medical products;Sales of Class II Medical Devices;Sales of Class I Medical Devices;pharmaceutical production;Drug internet information service;Drug Wholesale;Production of hygiene products and single-use medical products;Drug retail;Class III medical device business;Technology Import and Export;Import and export;Drug import and export;